120 related articles for article (PubMed ID: 19538164)
1. Synthesis, molecular targets, and antitumor activities of substituted tetrahydro-1-oxopyrano[4,3-b][1]benzopyrans and nanogels for drug delivery.
Perchellet EM; Perchellet JP; Ganta CK; Troyer DL; Shi A; Hua DH
Anticancer Agents Med Chem; 2009 Oct; 9(8):864-76. PubMed ID: 19538164
[TBL] [Abstract][Full Text] [Related]
2. Tricyclic pyrone analogs: a new synthetic class of bifunctional anticancer drugs that inhibit nucleoside transport, microtubule assembly, the viability of leukemic cells in vitro and the growth of solid tumors in vivo.
Perchellet EM; Ladesich JB; Magill MJ; Chen Y; Hua DH; Perchellet JP
Anticancer Drugs; 1999 Jun; 10(5):489-504. PubMed ID: 10477169
[TBL] [Abstract][Full Text] [Related]
3. Tricyclic pyrone analogs: a new class of microtubule-disrupting anticancer drugs effective against murine leukemia cells in vitro.
Newell SW; Perchellet EM; Ladesich JB; Freeman JA; Chen Y; Liu L; Hua DH; Kraft SL; Basaraba RJ; Perchellet JP
Int J Oncol; 1998 Feb; 12(2):433-42. PubMed ID: 9458372
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of tricyclic pyrone analogs, a new synthetic class of microtubule de-stabilizing agents, in the murine EMT-6 mammary tumor cell line in vitro.
Perchellet EM; Ladesich JB; Chen Y; Sin HS; Hua DH; Kraft SL; Perchellet JP
Anticancer Drugs; 1998 Jul; 9(6):565-76. PubMed ID: 9877246
[TBL] [Abstract][Full Text] [Related]
5. Combination of nanogel polyethylene glycol-polyethylenimine and 6(hydroxymethyl)-1,4-anthracenedione as an anticancer nanomedicine.
Ganta C; Shi A; Battina SK; Pyle M; Rana S; Hua DH; Tamura M; Troyer D
J Nanosci Nanotechnol; 2008 May; 8(5):2334-40. PubMed ID: 18572646
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of novel tricyclic pyrone analogs in murine leukemia cells in vitro.
Perchellet JP; Newell SW; Ladesich JB; Perchellet EM; Chen Y; Hua DH; Kraft SL; Basaraba RJ; Omura S; Tomoda H
Anticancer Res; 1997; 17(4A):2427-34. PubMed ID: 9252658
[TBL] [Abstract][Full Text] [Related]
7. Polyalkoxy substituted 4H-chromenes: synthesis by domino reaction and anticancer activity.
Shestopalov AM; Litvinov YM; Rodinovskaya LA; Malyshev OR; Semenova MN; Semenov VV
ACS Comb Sci; 2012 Aug; 14(8):484-90. PubMed ID: 22824131
[TBL] [Abstract][Full Text] [Related]
8. Antitumor agents. 178. Synthesis and biological evaluation of substituted 2-aryl-1,8-naphthyridin-4(1H)-ones as antitumor agents that inhibit tubulin polymerization.
Chen K; Kuo SC; Hsieh MC; Mauger A; Lin CM; Hamel E; Lee KH
J Med Chem; 1997 Sep; 40(19):3049-56. PubMed ID: 9301667
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of millepachine derivatives as a new class of tubulin polymerization inhibitors.
Wang G; Peng F; Cao D; Yang Z; Han X; Liu J; Wu W; He L; Ma L; Chen J; Sang Y; Xiang M; Peng A; Wei Y; Chen L
Bioorg Med Chem; 2013 Nov; 21(21):6844-54. PubMed ID: 23993668
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of novel chromene derivatives of expected antitumor activity.
Kandeel MM; Kamal AM; Abdelall EK; Elshemy HA
Eur J Med Chem; 2013 Jan; 59():183-93. PubMed ID: 23220647
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of a series of Homopterocarpane derivatives with potential antitumor and anti-AIDS activity.
Valenti P; Fabbri G; Rampa A; Bisi A; Belluti F
Farmaco; 1997 Jan; 52(1):13-9. PubMed ID: 9181675
[TBL] [Abstract][Full Text] [Related]
12. Triptycenes: a novel synthetic class of bifunctional anticancer drugs that inhibit nucleoside transport, induce DNA cleavage and decrease the viability of leukemic cells in the nanomolar range in vitro.
Perchellet EM; Magill MJ; Huang X; Brantis CE; Hua DH; Perchellet JP
Anticancer Drugs; 1999 Sep; 10(8):749-66. PubMed ID: 10573208
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of new 9-hydroxy-α- and 7-hydroxy-β-pyran naphthoquinones and cytotoxicity against cancer cell lines.
da Rocha DR; de Souza AC; Resende JA; Santos WC; dos Santos EA; Pessoa C; de Moraes MO; Costa-Lotufo LV; Montenegro RC; Ferreira VF
Org Biomol Chem; 2011 Jun; 9(11):4315-22. PubMed ID: 21487631
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of novel aldose reductase inhibitors: Effects on lens protein kinase Cgamma.
Lewis S; Karrer J; Saleh S; Chan X; Tan Z; Hua D; McGill J; Pang YP; Fenwick B; Brightman A; Takemoto D
Mol Vis; 2001 Jul; 7():164-71. PubMed ID: 11483892
[TBL] [Abstract][Full Text] [Related]
15. 2-Alkoxycarbonyl-3-arylamino-5-substituted thiophenes as a novel class of antimicrotubule agents: Design, synthesis, cell growth and tubulin polymerization inhibition.
Romagnoli R; Kimatrai Salvador M; Schiaffino Ortega S; Baraldi PG; Oliva P; Baraldi S; Lopez-Cara LC; Brancale A; Ferla S; Hamel E; Balzarini J; Liekens S; Mattiuzzo E; Basso G; Viola G
Eur J Med Chem; 2018 Jan; 143():683-698. PubMed ID: 29220790
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of novel pyranochalcone derivatives as a new class of microtubule stabilizing agents.
Cao D; Han X; Wang G; Yang Z; Peng F; Ma L; Zhang R; Ye H; Tang M; Wu W; Lei K; Wen J; Chen J; Qiu J; Liang X; Ran Y; Sang Y; Xiang M; Peng A; Chen L
Eur J Med Chem; 2013 Apr; 62():579-89. PubMed ID: 23425970
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, antitumor screening and cell cycle analysis of novel benzothieno[3,2-b]pyran derivatives.
Zaher AF; Abuel-Maaty SM; El-Nassan HB; Amer SA; Abdelghany TM
J Enzyme Inhib Med Chem; 2016; 31(sup4):145-153. PubMed ID: 27590401
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and anticancer evaluation of novel spirobenzo[h]chromene and spirochromane derivatives with dual EGFR and B-RAF inhibitory activities.
Abdelatef SA; El-Saadi MT; Amin NH; Abdelazeem AH; Omar HA; Abdellatif KRA
Eur J Med Chem; 2018 Apr; 150():567-578. PubMed ID: 29549841
[TBL] [Abstract][Full Text] [Related]
19. Novel nanogels as drug delivery systems for poorly soluble anticancer drugs.
Li N; Wang J; Yang X; Li L
Colloids Surf B Biointerfaces; 2011 Apr; 83(2):237-44. PubMed ID: 21159495
[TBL] [Abstract][Full Text] [Related]
20. Comparison of nanogel drug carriers and their formulations with nucleoside 5'-triphosphates.
Vinogradov SV; Kohli E; Zeman AD
Pharm Res; 2006 May; 23(5):920-30. PubMed ID: 16715382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
